Choosing effect measures in Axelium

Effect measures determine how study results are represented and pooled. Axelium suggests defaults by endpoint type, and you can override them when your protocol requires a different choice.

Binary outcomes

For outcomes that represent occurrence vs. non-occurrence of an event:

  • Risk Ratio (RR) — intuitive for relative risk comparisons; preferred for cohort and RCT designs where absolute risks are estimable.
  • Odds Ratio (OR) — common in case-control and logistic regression models; natural output when absolute event rates are not directly available.
  • Hazard Ratio (HR) — for time-to-event endpoints where censoring occurs; used in survival analysis contexts.

Continuous outcomes

For outcomes measured on a numeric scale:

  • Mean Difference (MD) — used when all studies report the same units; preserves clinical interpretability.
  • Standardized Mean Difference (SMD) — used when studies measure the same construct on different scales; expressed in standard deviation units.

Single-group prevalence

For prevalence and incidence estimates without a comparator:

  • Use pooled proportions with appropriate transformations (logit, Freeman-Tukey double arcsine) depending on whether extreme values are expected.
  • Random-effects assumptions are usually appropriate when pooling prevalence across heterogeneous populations.
Decision tree for choosing an effect measure based on outcome type and study design.

Practical selection checklist

  • Match the measure to the endpoint definition and study design.
  • Keep the measure consistent with your protocol registration.
  • Document overrides and rationale in your audit trail.
  • Consider clinical interpretability when choosing between RR and OR — when event rates differ substantially across populations, RRs are generally more informative.
Forest plot showing per-study effect sizes and pooled estimate
A forest plot in the Analysis tab: per-study effect sizes (with 95% CI), weights, and the pooled estimate from a random-effects model.